Cardiovascular and metabolic characteristics of infertile Chinese women with PCOS diagnosed according to the Rotterdam consensus criteria

Reproductive BioMedicine Online

Volumn 21, Issue 4, 2010, Pages 572-580

  Guo, M ^a,b   Chen, Z J ^b   MacKlon, N S ^a,c   Shi, Y H ^b   Westerveld, H E ^a   Eijkemans, M J ^a   Fauser, B C J M ^a   Goverde, A J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

ethnicity; infertility; insulin resistance; metabolic syndrome; polycystic ovary syndrome

Indexed keywords

ESTRADIOL; FOLLITROPIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; PROLACTIN; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; ANOVULATION; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHINESE; CHOLESTEROL BLOOD LEVEL; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FOLLITROPIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HIRSUTISM; HUMAN; HYPERANDROGENISM; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PROLACTIN BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; ANOVULATION; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; CHINA; FEMALE; GLUCOSE; HIRSUTISM; HUMANS; HYPERANDROGENISM; LIPID METABOLISM; METABOLIC SYNDROME X; PHENOTYPE; POLYCYSTIC OVARY SYNDROME;

EID: 78650520592     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rbmo.2010.04.032     Document Type: Article

References (46)

1. Alberti, K.G., Zimmet, P., Shaw, J. IDF Epidemiology Task Force Consensus Group, 2005. The metabolic syndrome-a new worldwide definition. Lancet 366,1059-1062.
2. American Diabetes Association, 2009. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 32(Suppl 1), S62-S67.
3. T. Apridonidze, P.A. Essah, M.J. Iuorno, and J.E. Nestler Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome Journal of Clinical Endocrinology and Metabolism 90 2005 1929 1935
4. R. Azziz Polycystic ovary syndrome, insulin resistance, and molecular defects of insulin signaling Journal of Clinical Endocrinology and Metabolism 87 2002 4085 4093
5. J.P. Baillargeon, and J.E. Nestler Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin? Journal of Clinical Endocrinology and Metabolism 91 2006 22 24
6. A.H. Balen, J.S. Laven, S.L. Tan, and D. Dewailly Ultrasound assessment of the polycystic ovary: international consensus definitions Human Reproduction Update 9 2003 505 514
7. T.M. Barber, M.I. McCarthy, J.A. Wass, and S. Franks Obesity and polycystic ovary syndrome Clinical Endocrinology 65 2006 137 145
8. I. Ben-Shlomo, R. Homburg, and E. Shalev Hyperandrogenic anovulation (the polycystic ovary syndrome) - back to the ovary? Human Reproduction Update 4 1998 296 300
9. F.J. Broekmans, E.A. Knauff, O. Valkenburg, J.S. Laven, M.J. Eijkemans, and B.C. Fauser PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factors British Journal of Obstetrics and Gynaecology 113 2006 1210 1217
10. E. Carmina, N. Napoli, R.A. Longo, G.B. Rini, and R.A. Lobo Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS European Journal of Endocrinology 154 2006 141 145
11. S.J. Chae, J.J. Kim, and Y.M. Choi Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women Human Reproduction 23 2008 1924 1931
12. W.Y. Chang, E.S. Knochenhauer, A.A. Bartolucci, and R. Azziz Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups Fertility and Sterility 83 2005 1717 1723
13. X. Chen, D. Yang, L. Li, S. Feng, and L. Wang Abnormal glucose tolerance in Chinese women with polycystic ovary syndrome Human Reproduction 21 2006 2027 2032
14. M.J. Chen, W.S. Yang, J.H. Yang, C.K. Hsiao, Y.S. Yang, and H.N. Ho Low sex hormone-binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS Human Reproduction 21 2006 2266 2271
15. L.P. Cheung, R.C. Ma, and P.M. Lam Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome Human Reproduction 23 2008 1431 1438
16. A.V. Chobanian, G.L. Bakris, and H.R. Black Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure Hypertension 42 2003 1206 1252
17. M. Ciampelli, F. Leoni, F. Cucinelli, S. Mancuso, S. Panunzi, A. De Gaetano, and A. Lanzone Assessment of insulin sensitivity from measurements in the fasting state and during an oral glucose tolerance test in polycystic ovary syndrome and menopausal patients Journal of Clinical Endocrinology and Metababolism 90 2005 1398 1406
18. A.J. Cussons, G.F. Watts, V. Burke, J.E. Shaw, P.Z. Zimmet, and B.G. Stuckey Cardio metabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome Human Reproduction 23 2008 2352 2358
19. E. Diamanti-Kandarakis, C. Kouli, K. Alexandraki, and G. Spina Failure of mathematical indices to accurately assess insulin resistance in lean, overweight, or obese women with polycystic ovary syndrome Journal of Clinical Endocrinology and Metababolism 89 2004 1273 1276
20. A. Dunaif Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis Endocrine Reviews 18 1997 774 800
21. D.A. Ehrmann, D.R. Liljenquist, K. Kasza, R. Azziz, R.S. Legro, and M.N. Ghazzi Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome Journal of Clinical Endocrinology and Metabolism 91 2006 48 53
22. D. Ferriman, and J.D. Gallwey Clinical assessment of body hair growth in women Journal of Clinical Endocrinology and Metabolism 21 1961 1440 1447
23. A.J. Goverde, A.J. van Koert, and M.J. Eijkemans Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria Human Reproduction 24 2009 710 717
24. S.M. Grundy, H.B. Brewer Jr, J.I. Cleeman, S.C. Smith Jr, and C. Lenfant Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition Circulation 109 2004 433 438
25. S.M. Grundy, J.I. Cleeman, and S.R. Daniels Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: Executive Summary Critical Pathways in Cardiology 4 2005 198 203
26. D. Gu, A. Gupta, and P. Muntner Prevalence of cardiovascular disease risk factor clustering among the adult population of China: results from the International Collaborative Study of Cardiovascular Disease in Asia (InterAsia) Circulation 112 2005 658 665
27. M. Gutt, C.L. Davis, and S.B. Spitzer Validation of the insulin sensitivity index (ISI (0, 120)): comparison with other measures Diabetes Research and Clinical Practice 47 2000 177 184
28. S. Hahn, S. Tan, and S. Elsenbruch Clinical and biochemical characterization of women with polycystic ovary syndrome in North Rhine-Westphalia Hormone and Metabolic Research 37 2005 438 444
29. Kauffman, R.P., Baker, T.E., Baker, V.M., DiMarino, P., Castracane, V.D., 2008. Endocrine and metabolic differences among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria. American Journal of Obstetrics and Gynecology. 198, 670.e1-670.e10.
30. P.M. Lam, W.H. Tam, and L.P. Cheung Higher metabolic risk in Chinese women fulfilling the NIH diagnostic criteria for polycystic ovarian syndrome Fertility and Sterility 91 Suppl. 4 2009 1493 1495
31. S.A. Lear, S. Kohli, G.P. Bondy, A. Tchernof, and A.D. Sniderman Ethnic variation in fat and lean body mass and the association with insulin resistance Journal of Clinical Endocrinology and Metabolism 94 2009 4697 4702
32. R.S. Legro, V.D. Castracane, and R.P. Kauffman Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls Obstetrical and Gynecological Survey 59 2004 141 154
33. R.S. Legro, C.L. Gnatuk, A.R. Kunselman, and A. Dunaif Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study Journal of Clinical Endocrinology and Metabolism 90 2005 3236 3242
34. L. Li, D. Yang, X. Chen, Y. Chen, F. Feng, and L. Wang Clinical and metabolic features of polycystic ovary syndrome International Journal of Gynecology and Obstetrics 97 2007 129 134
35. J.C. Lo, S.L. Feigenbaum, J. Yang, A.R. Pressman, J.V. Selby, and A.S. Go Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome Journal of Clinical Endocrinology and Metabolism 91 2006 1357 1363
36. H.R. Park, Y. Choi, H.J. Lee, J.Y. Oh, Y.S. Hong, and Y.A. Sung The metabolic syndrome in young Korean women with polycystic ovary syndrome Diabetes Research and Clinical Practice 77 Suppl 1 2007 S243 S246
37. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, 2004. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Fertility and Sterility. 81, 19-25.
38. S. Sam, and A. Dunaif Polycystic ovary syndrome: Syndrome XX? Trends in Endocrinology and Metabolism 14 2003 365 370
39. Y. Shi, X. Gao, X. Sun, P. Zhang, and Z. Chen Clinical and metabolic characteristics of polycystic ovary syndrome without polycystic ovary: a pilot study on Chinese women Fertility and Sterility 90 2008 1139 1143
40. R. Shroff, C.H. Syrop, W. Davis, B.J. Van Voorhis, and A. Dokas Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria Fertility and Sterility 88 2007 1389 1395
41. H.J. Teede, S. Hutchison, S. Zoungas, and C. Meyer Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS Endocrine 30 2006 45 53
42. H.E. Westerveld, M. Hoogendoorn, A.W. de Jong, A.J. Goverde, B.C. Fauser, and G.M. Dallinga-Thie Cardiometabolic abnormalities in the polycystic ovary syndrome: pharmacotherapeutic insights Pharmacology and Therapeutics 119 2008 223 241
43. H.J. Wei, R. Young, I.L. Kuo, C.M. Liaw, H.S. Chiang, and C.Y. Yeh Prevalence of insulin resistance and determination of risk factors for glucose intolerance in polycystic ovary syndrome: a cross-sectional study of Chinese infertility patients Fertility and Sterility 91 2009 1864 1868
44. C.K. Welt, J.A. Gudmundsson, and G. Arason Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: The impact of weight on phenotype and metabolic features Journal of Clinical Endocrinology and Metabolism 91 2006 4842 4848
45. S. Weerakiet, C. Srisombut, P. Bunnag, S. Sangtong, N. Chuangsoongnoen, and A. Rojanasakul Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in Asian women with polycystic ovary syndrome International Journal of Gynecology and Obstetrics 75 2001 177 184
46. J.K. Zawadski, and A. Dunaif Diagnostic criteria for polycystic ovary syndrome; towards a rational approach A. Dunaif, J. Givens, F. Haseltine, Polycystic Ovary Syndrome 1992 Blackwell Scientific Boston, USA 377 384